01 April, 2016 00:44
Human trials are scheduled for this year, with developers claiming Vasalgel could be available as early as 2018. File photo
Image by: ©Tatiana Shepeleva/shutterstock.com
Trials of Vasalgel, a non-hormonal male contraceptive, have indicated one injection can deliver safe and effective contraception to males for at least 12 months.
In the latest research, 12 male rabbits were given a single injection of Vasalgel in varying doses. Eleven were "azoospermic" straight away, and all 12 were unable to impregnate females throughout the year-long trial.
Moreover, the rabbits displayed no abnormal physical response to the injection.
Human trials are scheduled for this year, with developers claiming Vasalgel could be available as early as 2018.
"Results from our study in rabbits were even better than expected," said trial leader Donald Waller of the University of Illinois at Chicago. "Vasalgel produces a very rapid contraceptive effect which lasted throughout the study due to its unique hydrogel properties."
Vasalgel, owned by the medical research organisation the Parsemus Foundation, will be the first Food and Drug Administration approved male contraceptive since the condom - and could change the way we view contraception forever
collected by:http://www.timeslive.co.za/thetimes/2016/04/01/Male-birth-control-jab-on-the-way
0 comments:
Post a Comment